Separate mechanism from outcome
A receptor target or metabolic pathway does not by itself establish a clinical effect or approved use.
A laboratory reference hub for research materials associated with incretin biology, glucagon signaling, energy regulation, adipose biology, and mitochondrial metabolic pathways.
Identity, evidence context, documentation, and related laboratory research materials in one place.
This research area includes materials used to investigate receptor systems and cellular pathways involved in glucose handling, energy balance, adipose signaling, mitochondrial responses, and related metabolic biology. The evidence base varies substantially by material, from early mechanistic work to advanced human clinical development.
A receptor target or metabolic pathway does not by itself establish a clinical effect or approved use.
Some materials have extensive human data, while others remain preclinical or investigational.
Closely related analogues can have different receptor profiles, pharmacology, and evidence bases.
No materials are currently assigned to this research area.
A comparison of two mitochondrial-derived peptides and the distinct cellular research questions associated with each.
Read resource →A research-focused comparison of tirzepatide and retatrutide emphasizing receptor pharmacology, development status, and why the materials should not be treated as interchangeable.
Read resource →Why cagrilintide research and GLP-1-pathway research belong in the same metabolic conversation but should not be described as the same mechanism.
Read resource →Build a Research List, review available documentation, and send one wholesale inquiry to South Coast Peptides.